OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Iprivask

desirudin

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Iprivask
Proper name
desirudin
Licence type
351(a)
BLA number
021271
Applicant
Bausch Health US, LLC
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
15MG For Injection Subcutaneous Single-Dose Vial Disc April 4, 2003

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity